US Market News
1月前
Albemarle Reports First Quarter 2026 ResultsMay 6, 2026 4:15 PM
PR Newswire (US) CHARLOTTE, N.C., May 6, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2026. First Quarter 2026 and Recent Highlights
(Unless otherwise stated, all percentage changes represent year-over-year comparisons)Net sales of $1.4 billion, up 33% due to higher volumes and pricing in Energy Storage (volumes +14%, price +51%) and Specialties (volumes +7%, price +2%).Net income of $319 million, or $2.34 per diluted share attributable to common shareholders; Adjusted income of $2.95 per diluted share attributable to common shareholders(a). Adjusted EBITDA(a) of $664 million; up 148% due primarily to higher volumes and pricing in Energy Storage and Specialties and on-going cost and productivity improvements. Adjusted EBITDA expanded in both Energy Storage (+196%) and Specialties (+30%).Cash from operating activities of $346 million and free cash flow of $248 million(a). Capital expenditures of $99 million; maintaining full-year capital expenditure forecast of $550 million to $600 million.Delivered $40 million in cost and productivity improvements, on track to achieve full-year target of $100 million to $150 million.Closed sales of Eurecat joint venture and controlling stake in Ketjen for a combined $648 million net cash proceeds.Completed debt reduction actions that resulted in paying down $1.3 billion of outstanding debt and lowering the weighted average interest rate.Improved 2026 outlook considerations, including increased full-year Specialties outlook for both sales and adjusted EBITDA, primarily due to higher prices, and reduced interest expense following recent debt reduction actions. Maintaining enterprise outlook scenarios as these improvements are expected to offset higher costs related to supply chain disruptions in the Middle East.(a) See Non-GAAP Reconciliations for further details."Albemarle had a strong start to 2026, with net sales and adjusted EBITDA up year over year. Higher pricing and volumes in Energy Storage and Specialties, along with continued cost and productivity actions, were the key contributors to our results," said Kent Masters, Chairman and CEO. "We also took advantage of our successful cash and portfolio management actions to pay down debt in the quarter, further strengthening our balance sheet and financial flexibility. As the global operating environment remains uncertain, we are focused on the things within our control, including operational excellence, cost and productivity discipline, and cash generation, to enable long-term volume and earnings growth."First Quarter 2026 ResultsIn millions, except per share amountsQ1 2026
Q1 2025
$ Change
% ChangeNet sales$ 1,428.7
$ 1,076.9
$ 351.9
32.7 %Net income attributable to Albemarle Corporation$ 319.1
$ 41.3
$ 277.7
671.7 %Adjusted EBITDA(a)$ 663.8
$ 267.1
$ 396.7
148.5 %Diluted income (loss) per share attributable to common shareholders$ 2.34
$ (0.00)
$ 2.34
NM Non-operating pension and OPEB items(a)0.01
—
Non-recurring and other unusual items(a)0.60
(0.18)
Adjusted diluted income (loss) per share attributable to common shareholders(a)(b)$ 2.95
$ (0.18)
$ 3.13
NM
(a)See Non-GAAP Reconciliations for further details.(b)Totals may not add due to rounding.Net sales for the first quarter of 2026 were $1.4 billion compared to $1.1 billion for the prior-year quarter, up 33%, driven primarily by higher price and volume in both Energy Storage and Specialties. The divestiture of Ketjen reduced net sales by 4% versus prior year. Adjusted EBITDA of $664 million increased by $397 million from the prior-year quarter, primarily due to higher net sales and on-going cost and productivity improvements. Net income attributable to Albemarle of $319 million increased year over year by $278 million. The effective income tax rate for the first quarter of 2026 was 8.5% compared to 21.0% in the same period of 2025. On an adjusted basis, the effective income tax rates were 5.2% and (42.8)% for the first quarters of 2026 and 2025, respectively, with the change primarily due to geographic income mix including higher income in jurisdictions with net operating losses or tax valuation allowances.Energy Storage ResultsIn millionsQ1 2026
Q1 2025
$ Change
% ChangeNet Sales$ 891.2
$ 524.6
$ 366.6
69.9 %Adjusted EBITDA$ 551.4
$ 186.4
$ 365.0
195.9 %Energy Storage net sales for the first quarter of 2026 were $891 million, an increase of $367 million, or 70%, due to higher pricing (+51%) and volumes (+14%). Adjusted EBITDA of $551 million increased $365 million, or 196%, primarily due to higher lithium pricing, spodumene inventory timing, and cost and productivity improvements.Specialties ResultsIn millionsQ1 2026
Q1 2025
$ Change
% ChangeNet Sales$ 358.4
$ 321.0
$ 37.4
11.7 %Adjusted EBITDA$ 76.1
$ 58.7
$ 17.5
29.8 %Specialties net sales for the first quarter of 2026 were $358 million, an increase of $37 million, or 12%, primarily due to higher volumes (+7%) and pricing (+2%). Adjusted EBITDA of $76 million increased $17 million, or 30%, due to higher net sales and cost and productivity improvements. 2026 Outlook ConsiderationsTotal Corporate Outlook Considerations
The table below reflects expected outcomes for the total company based on recently observed lithium market price scenarios. Outlook ranges for each scenario are based on variation in sales volume and product mix. Energy Storage production volumes are expected to increase year over year. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025. All three scenarios assume flat market pricing flowing through Energy Storage's current contract book which includes approximately 40% of salts volume on long-term agreements. Scenarios also assume that spodumene pricing averages 10% of the lithium carbonate equivalent (LCE) price, while other costs are assumed to be constant.
Total Corporate FY 2026E Observed market price case(a)FY 2025 avg.Q1 2026 avg.2021-2025 avg.Average lithium market price ($/kg LCE)(a)~$10~$20~$30Net sales$4.1 - $4.3 billion$5.7 - $6.0 billion$7.5 - $7.8 billionAdjusted EBITDA(b)$0.9 - $1.0 billion$2.4 - $2.6 billion$4.2 - $4.4 billion
(a)Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.(b)The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See "Additional Information Regarding Non-GAAP Measures" for more information.Energy Storage Market Price Scenarios
Energy Storage FY 2026E Observed market price case(a)FY 2025 avg.Q1 2026 avg.2021-2025 avg.Average lithium market price ($/kg LCE)(a)~$10~$20~$30Net sales$2.5 - $2.6 billion$4.0 - $4.2 billion$5.9 - $6.1 billionAdjusted EBITDA$0.7 - $0.8 billion$2.1 - $2.3 billion$3.9 - $4.1 billionEquity in net income of unconsolidated investments (net of tax)(b)$0.2 - $0.3 billion$0.6 - $0.7 billion$1.0 - $1.1 billion
(a)Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.(b)Included in adjusted EBITDA on a pre-tax basis.Specialties Outlook Considerations
Specialties net sales and adjusted EBITDA outlook is improved primarily due to higher-than-expected bromine pricing in Chinese and Indian spot markets. Our outlook continues to reflect modest volume growth in key end markets led by semiconductors, oil and gas, flame retardants and pharmaceuticals partially offset by expected softness in automotive and petrochemicals. Operations at the Jordan Bromine Company (JBC) joint venture have fully recovered from the flooding event in late December 2025 and continue to operate despite geopolitical tensions in the region.
Segment FY 2026ESpecialties net sales$1.3 - $1.5 billionSpecialties adjusted EBITDA$225 - $275 millionOther Corporate Outlook Considerations
Albemarle expects its 2026 capital expenditures to be roughly flat compared to 2025, in the range of $550 million to $600 million.Following the sale of a controlling stake in Ketjen, announced on March 2, 2026, the refining catalyst business earnings are now classified as equity income and included in Corporate, as are the results of the retained Performance Catalyst Solutions (PCS) business. The adjusted EBITDA and equity income contributions from these are expected to be immaterial post transaction.Interest and financing expense is now expected to be between $120 and $140 million for 2026 following the debt reduction actions completed in the first quarter of 2026.
Other Corporate FY 2026E Capital expenditures$550 - $600 millionDepreciation and amortization $660 - $680 millionAdjusted effective tax rate(a)(50)% - 30%Corporate adjusted EBITDA (incl. FX, Ketjen equity income & PCS)($20) - $20 millionInterest and financing expenses$120 - $140 millionWeighted-average common shares outstanding (diluted)(b)~118 million
(a)Adjusted effective tax rate dependent on lithium market prices and geographic income mix(b)Diluted weighted-average common shares outstanding amount assumes the net income attributable to common shareholders will be reduced by mandatory convertible preferred stock dividends. If the assumed conversion of preferred stock results in a more dilutive earnings per share, the diluted weighted-average common shares outstanding will reflect this conversion.Cash Flow and Capital Deployment
Cash from operations of $346 million in the first three months of 2026 decreased $201 million compared to the prior-year period. First quarter 2025 cash from operations included a one-time $350 million customer prepayment. Capital expenditures of $99 million in the first three months of 2026 decreased by $84 million versus the prior-year period.Balance Sheet and Liquidity
As of March 31, 2026, Albemarle had estimated liquidity of approximately $2.7 billion, including $1.1 billion of cash and cash equivalents, $1.5 billion available under our revolver and $87 million available under other credit lines. Total debt was $1.9 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 1.0. In March, the company completed debt reduction actions that resulted in paying down $1.3 billion of outstanding debt and lowering the weighted average interest rate.Earnings CallDate:Thurs., May 7, 2026Time:8:00 AM Eastern timeDial-in (U.S.):1-800-590-8290Dial-in (International):1-240-690-8800Conference ID:ALBQ1The company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com.About Albemarle
Albemarle Corporation (NYSE: ALB) is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.Forward-Looking Statements
This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "ambition," "anticipate," "believe," "estimate," "expect," "goal," "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will." Forward-looking statements may include statements regarding: our 2026 company and segment outlooks, including guidance related to impact on 2026 EBITDA, volumes, and cash flow; plans and expectations regarding customer demand and sales; production impacts; financial flexibility and optionality; expected or actual market pricing of lithium, spodumene, bromine, and lithium specialties ("Company Products"); supply and demand for Company Products; drivers of long-term demand and growth; other underlying assumptions and outlook considerations; expected capital allocation and expenditure amounts and the corresponding impact on cash flow; plans and expectations regarding other mining interests, resources, reserves, projects and activities, compound annual growth rate, cost reductions, conversion network optimization, margin improvement, accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; changes in trade policies and tariffs; and the financial and operating performance of customers; timing and magnitude of customer orders; fluctuations in market pricing of lithium carbonate equivalent and spodumene; potential production volume shortfalls; increased competition and pressure to renegotiate contract terms; changes in product or conversion demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; political unrest affecting global trade, including tensions in the Middle East; the global economy and clean energy initiatives; changes in inflation or interest rates; volatility and uncertainties in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; expected benefits and expenses from new operating structure and asset optimization activities; performance of Albemarle's partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this presentation. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws. Albemarle Corporation and SubsidiariesConsolidated Statements of Income(In Thousands Except Per Share Amounts) (Unaudited)
Three Months Ended
March 31,
2026
2025Net sales$ 1,428,731
$ 1,076,881Cost of goods sold927,765
920,582Gross profit500,966
156,299Selling, general and administrative expenses137,406
123,502Restructuring charges and asset write-offs25,866
(1,063)Research and development expenses9,170
14,099Loss on sale of business95,018
—Operating income233,506
19,761Interest and financing expenses(33,121)
(48,977)Other income, net53,810
10,250Income (loss) before income taxes and equity in net income of unconsolidated investments254,195
(18,966)Income tax expense (benefit)21,511
(3,978)Income (loss) before equity in net income of unconsolidated investments232,684
(14,988)Equity in net income of unconsolidated investments (net of tax)96,293
64,286Net income328,977
49,298Net income attributable to noncontrolling interests(9,886)
(7,950)Net income attributable to Albemarle Corporation319,091
41,348Mandatory convertible preferred stock dividends(41,688)
(41,688)Net income (loss) attributable to Albemarle Corporation common shareholders$ 277,403
$ (340)Basic earnings (loss) per share attributable to common shareholders$ 2.35
$ (0.00)Diluted earnings (loss) per share attributable to common shareholders$ 2.34
$ (0.00)
Weighted-average common shares outstanding – basic117,854
117,603Weighted-average common shares outstanding – diluted118,607
117,603 Albemarle Corporation and SubsidiariesCondensed Consolidated Balance Sheets(In Thousands) (Unaudited)
March 31,
December 31,
2026
2025ASSETS
Current assets:
Cash and cash equivalents$ 1,089,809
$ 1,618,001Trade accounts receivable522,715
593,502Other accounts receivable136,767
105,110Inventories1,346,960
1,179,271Other current assets162,932
140,440Current assets held for sale—
371,815Total current assets3,259,183
4,008,139Property, plant and equipment11,822,899
11,768,840Less accumulated depreciation and amortization3,297,806
3,156,429Net property, plant and equipment8,525,093
8,612,411Investments1,022,707
900,926Other assets636,574
647,185Goodwill1,488,404
1,499,657Other intangibles, net of amortization207,617
214,233Noncurrent assets held for sale—
491,660Total assets$ 15,139,578
$ 16,374,211LIABILITIES AND EQUITY
Current liabilities:
Accounts payable to third parties$ 677,151
$ 779,160Accounts payable to related parties256,630
134,369Accrued expenses452,927
521,831Current portion of long-term debt74,628
74,077Dividends payable61,456
61,387Income taxes payable53,139
35,467Current liabilities held for sale—
191,753Total current liabilities1,575,931
1,798,044Long-term debt1,807,203
3,119,464Postretirement benefits45,075
44,744Pension benefits115,451
117,361Other noncurrent liabilities1,118,508
1,084,892Deferred income taxes369,294
368,275Noncurrent liabilities held for sale—
59,970Commitments and contingencies
Equity:
Albemarle Corporation shareholders' equity:
Common stock1,179
1,178Mandatory convertible preferred stock2,235,105
2,235,105Additional paid-in capital3,029,667
3,018,213Accumulated other comprehensive loss(259,112)
(334,807)Retained earnings4,843,335
4,613,676Total Albemarle Corporation shareholders' equity9,850,174
9,533,365Noncontrolling interests257,942
248,096Total equity10,108,116
9,781,461Total liabilities and equity$ 15,139,578
$ 16,374,211 Albemarle Corporation and SubsidiariesSelected Consolidated Cash Flow Data(In Thousands) (Unaudited)
Three Months EndedMarch 31,
2026
2025Cash and cash equivalents at beginning of year$ 1,618,001
$ 1,192,230Cash flows from operating activities:
Net income328,977
49,298Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization157,805
161,754Loss on sale of business95,018
—Gain on sale of equity investment(42,300)
—Stock-based compensation and other7,883
6,966Equity in net income of unconsolidated investments (net of tax)(96,293)
(64,286)Dividends received from unconsolidated investments and nonmarketable securities—
60,335Pension and postretirement expense2,921
1,696Pension and postretirement contributions(3,204)
(5,196)Unrealized loss on investments in marketable securities5,137
5,331Gain on early extinguishment of debt(12,591)
—Deferred income taxes(1,005)
(5,669)Working capital changes(144,430)
(21,992)Noncurrent liability changes and other, net48,326
358,970Net cash provided by operating activities346,244
547,207Cash flows from investing activities:
Capital expenditures(98,676)
(182,624)Proceeds from sale of businesses, net of cash sold525,156
—Proceeds from sale of investments123,270
—(Payments) proceeds from settlement of foreign currency forward contracts, net(10,514)
50,245Sales of marketable securities, net1,785
3,381Investments in equity investments and nonmarketable securities(59)
(60)Net cash provided by (used in) investing activities540,962
(129,058)Cash flows from financing activities:
Repayments of long-term debt and credit agreements(1,296,595)
(9,615)Proceeds from borrowings of long-term debt and credit agreements18,396
—Other debt repayments, net(11,237)
(1,195)Fees related to early extinguishment of debt(1,639)
—Dividends paid to common shareholders(47,667)
(47,607)Dividends paid to mandatory convertible preferred shareholders(41,688)
(41,688)Dividends paid to noncontrolling interests(37,462)
(18,169)Proceeds from exercise of stock options8,917
1,186Withholding taxes paid on stock-based compensation award distributions(3,939)
(2,904)Other(438)
(14)Net cash used in financing activities(1,413,352)
(120,006)Net effect of foreign exchange on cash and cash equivalents(2,046)
28,138(Decrease) increase in cash and cash equivalents(528,192)
326,281Cash and cash equivalents at end of period$ 1,089,809
$ 1,518,511 Albemarle Corporation and SubsidiariesConsolidated Summary of Segment Results(In Thousands) (Unaudited)
Three Months Ended
March 31,
2026
2025Net sales:
Energy Storage$ 891,165
$ 524,565Specialties358,413
321,014Total segment net sales1,249,578
845,579Corporate and all other179,153
231,302Total net sales$ 1,428,731
$ 1,076,881
Adjusted EBITDA:
Energy Storage$ 551,356
$ 186,355Specialties76,129
58,666Total segment adjusted EBITDA627,485
245,021Corporate and all other36,329
22,123Total adjusted EBITDA$ 663,814
$ 267,144See accompanying non-GAAP reconciliations below.Additional Information Regarding Non-GAAP MeasuresIt should be noted that adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, adjusted diluted income (loss) per share attributable to common shareholders, non-operating pension and other post-employment benefit ("OPEB") items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net income attributable to Albemarle Corporation ("earnings") or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company's operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company's chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle's website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliations
(Unaudited)See below for a reconciliation of adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net income attributable to Albemarle Corporation is defined as net income attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net income (loss) attributable to Albemarle Corporation common stockholders is defined as adjusted net income attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net income attributable to Albemarle Corporation before interest and financing expenses, income tax expense (benefit), and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring, other unusual and non-operating pension and OPEB items as listed below.
Three Months Ended
March 31,
2026
2025In thousands, except percentages and per share amounts$
% of
net
sales
$
% of
net
salesNet income attributable to Albemarle Corporation$ 319,091
$ 41,348
Add back:
Non-operating pension and OPEB items (net of tax)971
125
Non-recurring and other unusual items (net of tax)81,390
(21,200)
Adjusted net income attributable to Albemarle Corporation401,452
20,273
Mandatory convertible preferred stock dividends(a)—
(41,688)
Adjusted net income (loss) attributable to Albemarle Corporation common shareholders$ 401,452
$ (21,415)
Adjusted diluted income (loss) per share attributable to common shareholders$ 2.95
$ (0.18)
Adjusted weighted-average common shares outstanding – diluted(a)136,128
117,603
Net income attributable to Albemarle Corporation$ 319,091
22.3 %
$ 41,348
3.8 %Add back:
Interest and financing expenses33,121
2.3 %
48,977
4.5 %Income tax expense (benefit)21,511
1.5 %
(3,978)
(0.4) %Depreciation and amortization157,805
11.0 %
161,754
15.0 %EBITDA531,528
37.2 %
248,101
23.0 %Proportionate share of Windfield income tax expense41,534
2.9 %
25,326
2.4 %Non-operating pension and OPEB items1,347
0.1 %
275
— %Non-recurring and other unusual items89,405
6.3 %
(6,558)
(0.6) %Adjusted EBITDA$ 663,814
46.5 %
$ 267,144
24.8 %
Net sales$ 1,428,731
$ 1,076,881
(a) Calculation of adjusted diluted income (loss) per share attributable to common shareholders for the three months ended March 31, 2026 excludes $41.7 million of mandatory convertible preferred stock dividends and includes the assumed conversion of preferred stock into the diluted shares outstanding, as this results in the more dilutive per share result.Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle's operating segments and are included in the Corporate and all other category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company's businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other income, net. Non-operating pension and OPEB items were as follows (in thousands):
Three Months Ended
March 31,
2026
2025Interest cost $ 9,041
$ 8,810Expected return on assets(7,694)
(8,535)Total$ 1,347
$ 275In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle's adjusted net income (loss) calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):
Three Months Ended
March 31,
2026
2025Restructuring charges and asset write-offs(1)$ 0.19
$ (0.02)Acquisition and integration related costs(2)0.01
0.01Loss on sale of business/equity investment, net(3)0.39
—Gain on early extinguishment of debt(4)(0.09)
—Loss in fair value of public equity securities(5)0.04
0.03Other(6)0.03
(0.08)Tax related items(7)0.03
(0.12)Total non-recurring and other unusual items$ 0.60
$ (0.18)
(1)During the three months ended March 31, 2026, the Company announced it would place Kemerton Train 1 into care and maintenance. The three months ended March 31, 2025 included certain restructuring costs and adjustments to previously recorded costs related to restructuring actions originally entered into in 2024. As a result, the Company recorded charges (gains) of $25.9 million and ($1.1 million) in Restructuring charges and asset write-offs for the three months ended March 31, 2026 and 2025, respectively, and losses of $0.2 million in Other income, net for the three months ended March 31, 2025. Due to the impact of valuation allowances, this resulted in total after-tax losses (gains) of $25.9 million, or $0.19 per share, and ($2.1) million, or ($0.02) per share, for the three months ended March 31, 2026 and 2025, respectively.
(2)Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three months ended March 31, 2026 and 2025 were $1.1 million and $1.4 million ($1.1 million and $1.1 million after income taxes due to the impact of valuation allowances, or $0.01 and $0.01 per share), respectively.
(3)During the first quarter of 2026, the Company divested its controlling ownership interest in its Refining Solutions business and its full 50% ownership interest in the Eurecat joint venture. As a result of these transactions, the Company recorded a net loss of $52.7 million ($0.39 per share, with no income tax effect due to the impact of valuation allowances), representing the proceeds received less the carrying value as of the transaction dates.
(4)During the first quarter of 2026, the Company completed a $1.3 billion debt tender and redemption, resulting in a gain on early extinguishment of debt of $12.6 million ($0.09 per share, with no income tax effect due to the impact of valuation allowances), representing the repurchase of this debt at a discount, partially offset by tender premiums and redemption fees.
(5)Losses resulting from the net change in fair value of investments in public equity securities, recorded in Other income, net for the three months ended March 31, 2026 and 2025 of $5.5 million and $5.0 million ($5.5 million and $3.9 million after income taxes, or $0.04 and $0.03 per share), respectively.
(6)Other adjustments for the three months ended March 31, 2026 included amounts recorded in:
Selling, general and administrative expenses - primarily related to a $3.9 million charge for a non-income tax audit of a facility no longer controlled by the Company
After income taxes, these net losses totaled $4.2 million, or $0.03 per share.
Other adjustments for the three months ended March 31, 2025 included amounts recorded in:
Selling, general and administrative expenses - $3.2 million of gains from the sale of assets at a site not part of our operations, partially offset by $0.6 million of expenses related to certain historical legal matters.
Other income, net - $9.8 million of income from PIK dividends of preferred equity in a Grace subsidiary and a $1.9 million gain primarily resulting from the adjustment of indemnification related to previously disposed businesses, partially offset by $1.9 million of charges for asset retirement obligations at a site not part of our operations.
After income taxes, these net gains totaled $9.8 million, or $0.08 per share.
(7)Included in Income tax expense (benefit) for the three months ended March 31, 2026 are discrete net tax expenses of $4.6 million, or $0.03 per share, primarily related to the impact of foreign tax reserves.
Included in Income tax expense (benefit) for the three months ended March 31, 2025 are discrete net tax benefits of $14.2 million, or $0.12 per share, primarily related to the reduction in a foreign tax reserve and excess tax benefits realized from stock-based compensation arrangements.See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).
Income (loss) before
income taxes and
equity in net income
of unconsolidated
investments
Income tax expense
(benefit)
Effective income tax
rateThree months ended March 31, 2026
As reported$ 254,195
$ 21,511
8.5 %Non-recurring, other unusual and non-operating pension and OPEB items78,162
(4,199)
As adjusted$ 332,357
$ 17,312
5.2 %
Three months ended March 31, 2025
As reported$ (18,966)
$ (3,978)
21.0 %Non-recurring, other unusual and non-operating pension and OPEB items(6,283)
14,792
As adjusted$ (25,249)
$ 10,814
(42.8) %See below for the reconciliation of free cash flow, a non-GAAP measure, to net cash provided by operating activities, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).
Three Months Ended
March 31, 2026Free cash flow:
Net cash provided by operating activities$ 346,244Less: Capital expenditures(98,676)Free cash flow$ 247,568 Albemarle Investor Relations Contact: +1 (980) 308-6194, invest@albemarle.com View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-reports-first-quarter-2026-results-302764556.htmlSOURCE Albemarle Corporation Original: Albemarle Reports First Quarter 2026 Results
US Market News
4月前
Albemarle Reports Fourth Quarter and Full Year 2025 ResultsFebruary 11, 2026 4:15 PM
PR Newswire (US)
CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter and Full Year 2025 Results and Highlights
(Unless otherwise stated, all percentage changes represent year-over-year comparisons)Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of ($414) million, or ($3.87) per diluted share, includes tax-related items and the write-down of assets in relation to the expected Ketjen transaction value; adjusted diluted loss per share of ($0.53)(a).Fourth quarter adjusted EBITDA(a) of $269 million, up 7%, led by Energy Storage (+25%) and Ketjen (+39%).Full year cash from operations of $1.3 billion, representing more than 100% operating cash flow conversion(b), driven primarily by cost and productivity improvements, working capital management, and a customer pre-payment received in January 2025.Free cash flow of $692 million(a) reflects strong operating cash flow conversion and significantly lower capital expenditures of $590 million (down 65% year-over-year).Achieved approximately $450 million of cost and productivity improvements, exceeding the initial target of $300 to $400 million.Closed sale of 50% stake in the Eurecat joint venture for $123 million cash in January 2026; on track to close sale of controlling stake in Ketjen in Q1 2026.Introducing full-year 2026 outlook considerations, including ranges based on updated lithium market price scenarios:New scenarios highlight improved lithium market conditions and operational performance.Full-year 2026 capital expenditures expected to be approximately flat year-over-year, reflecting consistent sustaining capital, Ketjen divestiture and targeted growth capital focused on productivity gains and resource development.Meaningful free cash flow generation assuming recent higher lithium prices.(a)See Non-GAAP Reconciliations for further details.(b) Defined as Operating Cash Flow divided by Adj. EBITDA, which is a non-GAAP measure. See Non-GAAP Reconciliations for further details."Our results for the fourth quarter and full year 2025 are a testament to our team's focus on execution amid dynamic market conditions. Albemarle achieved year-over-year sales growth of more than 15% in the fourth quarter, as well as strong full-year cash flow generation and significant cost and productivity improvements," said Kent Masters, Chairman and CEO. "The steps we have taken to optimize our asset portfolio, reduce costs and strengthen our financial flexibility have improved our competitive position. Even as market conditions improve, we continue to drive cost reduction and productivity actions to enable long-term growth, powered by our world-class resources."Fourth Quarter 2025 ResultsIn millions, except per share amountsQ4 2025
Q4 2024
$ Change
% Change(c)Net sales$ 1,428.0
$ 1,231.7
$ 196.3
15.9 %Net (loss) income attributable to Albemarle Corporation$ (414.2)
$ 75.3
$ (489.5)
NMAdjusted EBITDA(a)$ 268.7
$ 250.7
$ 18.0
7.2 %Diluted (loss) earnings per share attributable to common shareholders$ (3.87)
$ 0.29
$ (4.16)
NM Non-operating pension and OPEB items(a)0.15
(0.07)
Non-recurring and other unusual items(a)3.19
(1.31)
Adjusted diluted loss per share attributable to common shareholders(a)(b)$ (0.53)
$ (1.09)
$ 0.56
51.4 %
(a)See Non-GAAP Reconciliations for further details.(b)Totals may not add due to rounding.(c)Certain percentage changes are considered not meaningful ("NM")Net sales for the fourth quarter of 2025 were $1.4 billion compared to $1.2 billion for the prior-year quarter, an increase of 16%, driven primarily by higher volumes in Energy Storage (+17%) and Ketjen (+13%) and higher pricing in Energy Storage. Net loss attributable to Albemarle of $414 million increased year-over-year by $490 million primarily due to tax-related items and the write-down of assets in relation to the expected Ketjen transaction value. Excluding these one-time items, adjusted net loss improved year-over-year. Adjusted EBITDA of $269 million increased by $18 million from the prior-year quarter primarily due to higher pricing in Energy Storage and higher volumes in Ketjen.The effective income tax rate for the fourth quarter of 2025 was (55.2)%, compared to 13.8% in the same period of 2024. On an adjusted basis, the effective income tax rates were 561.1% and 446.9% for the fourth quarters of 2025 and 2024, respectively, with the increase primarily due to recording a valuation allowance on the entirety of U.S. deferred tax assets in the fourth quarter of 2025, as well as changes in geographic income mix, including the impact of previously recorded valuation allowances in Australia and China.Energy Storage ResultsIn millionsQ4 2025
Q4 2024
$ Change
% ChangeNet Sales$ 759.1
$ 616.8
$ 142.2
23.1 %Adjusted EBITDA$ 167.1
$ 133.7
$ 33.4
25.0 %Energy Storage net sales for the fourth quarter of 2025 were $759 million, an increase of $142 million, or 23%, primarily due to higher volumes (+17%) and pricing (+6%). Adjusted EBITDA of $167 million increased $33 million, or 25%, primarily due to higher pricing and cost and productivity improvements.Energy Storage adjusted EBITDA for the full year 2025 was $697 million, down 8% versus the year prior, as higher sales volumes and cost and productivity improvements mostly offset lower lithium market pricing.Specialties ResultsIn millionsQ4 2025
Q4 2024
$ Change
% ChangeNet Sales$ 348.9
$ 332.9
$ 16.0
4.8 %Adjusted EBITDA$ 68.6
$ 72.9
$ (4.3)
(5.9) %Specialties net sales for the fourth quarter of 2025 were $349 million, an increase of $16 million, or 5%, primarily due to higher volumes (+2%) and pricing (+1%). Adjusted EBITDA of $69 million decreased $4 million versus the year-ago quarter primarily due to margin compression in lithium specialties, down from 2024 highs.Specialties adjusted EBITDA for the full year 2025 was $276 million, increasing 21% year-over-year, as higher volumes and cost and productivity improvements more than offset lower pricing.Ketjen ResultsIn millionsQ4 2025
Q4 2024
$ Change
% ChangeNet Sales$ 320.1
$ 281.9
$ 38.1
13.5 %Adjusted EBITDA$ 49.7
$ 35.8
$ 13.9
38.8 %Ketjen net sales for the fourth quarter of 2025 were $320 million, up 14% compared to the prior-year quarter primarily due to higher fluidized catalytic cracking (FCC) volumes and timing of Clean Fuels technology (CFT) sales. Adjusted EBITDA of $50 million increased $14 million, driven by favorable product mix and lower input costs.Ketjen adjusted EBITDA for the full year 2025 was $150 million, an increase of 15%, primarily due to increased FCC volumes.2026 Outlook ConsiderationsTotal Corporate Outlook Considerations
The table below reflects expected outcomes for the total company based on recently observed lithium market price scenarios. Outlook ranges for each scenario are based on variation in sales volume and product mix. Energy Storage production volumes are expected to increase year-over-year. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025. All three scenarios assume flat market pricing flowing through Energy Storage's current contract book which includes approximately 40% of salts volume on long-term agreements. Scenarios also assume that spodumene pricing averages 10% of the lithium carbonate equivalent (LCE) price, while other costs are assumed to be constant.
Total Corporate FY 2026E Including Energy Storage ScenariosObserved market price case(a)FY 2025 avg.Jan. 2026 avg.2021-2025 avg.Average lithium market price ($/kg LCE)(a)~$10~$20~$30Net sales$4.1 - $4.3 billion$5.7 - $6.0 billion$7.5 - $7.8 billionAdjusted EBITDA(b)$0.9 - $1.0 billion$2.4 - $2.6 billion$4.2 - $4.4 billion
(a)Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.(b)The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measurescalculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort.See "Additional information regarding Non-GAAP Measures" for more information.Energy Storage Market Price Scenarios
Energy Storage FY 2026E Observed market price case(a)FY 2025 avg.Jan. 2026 avg.2021-2025 avg.Average lithium market price ($/kg LCE)(a)~$10~$20~$30Net sales$2.5 - $2.6 billion$4.0 - $4.2 billion$5.9 - $6.1 billionAdjusted EBITDA$0.7 - $0.8 billion$2.1 - $2.3 billion$3.9 - $4.1 billionEquity in net income of unconsolidated investments (net of tax)(b)$0.2 - $0.3 billion$0.6 - $0.7 billion$1.0 - $1.1 billion
(a)Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.(b)Included in adjusted EBITDA on a pre-tax basis.Specialties Outlook Considerations
Specialties outlook reflects modest volume growth in key end markets led by semiconductor and pharmaceutical partially offset by expected softness in automotive, building and construction and oil and gas.Net sales are expected to be flat to down and adjusted EBITDA is expected to be lower in 2026 compared to 2025 due, in part, to lithium specialties pricing, which has adjusted lower from the previous peak, and reduced demand for clear brine fluids due to weakness in oil and gas markets. Production volume in 2026 is expected to be impacted by a major flooding event that occurred at our Jordan Bromine Company (JBC) joint venture in January 2026. JBC has since returned to full operating rates.
Segment FY 2026ESpecialties net sales$1.2 - $1.4 billionSpecialties adjusted EBITDA$170 - $230 millionOther Corporate Outlook ConsiderationsFollowing the sale of a controlling stake in Ketjen, which is expected to close in the first quarter of 2026, the refining catalyst business earnings will be classified as equity income and included in Corporate, as will the results of the retained Performance Catalyst Solutions (PCS) business. The EBITDA and equity income contributions from these are expected to be immaterial post transaction.Albemarle expects its 2026 capital expenditures to be roughly flat compared to 2025, in the range of $550 million to $600 million.
Other Corporate FY 2026ECapital expenditures$550 - $600 millionDepreciation and amortization $660 - $680 millionAdjusted effective tax rate(a)(50%) - 30%Corporate adjusted EBITDA (incl. FX, Ketjen equity income & PCS)($20) - $20 millionInterest and financing expenses$150 - $170 millionWeighted-average common shares outstanding (diluted)~118 million
(a)Adjusted effective tax rate dependent on lithium market prices and geographic income mixCash Flow and Capital Deployment
Cash from operations of $1.3 billion for the year ended December 31, 2025 increased $594 million compared to the prior-year period due to cost and productivity improvements, cash management actions, including inventory reductions, and a customer prepayment received in January. Capital expenditures of $590 million were in-line with the company's most recent outlook and decreased by $1.1 billion versus the prior-year period, reflecting the impact of decisions that stopped or slowed spending and the completion of capacity expansions in Energy Storage and Specialties.Balance Sheet and Liquidity
As of December 31, 2025, Albemarle had estimated liquidity of approximately $3.2 billion, including $1.6 billion of cash and equivalents, $1.5 billion available under its revolver and $105 million available on other credit lines. Total debt was $3.2 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 2.0 times.Earnings CallDate:Thurs., Feb. 12, 2026Time:8:00 AM Eastern timeDial-in (U.S.): +1 800-590-8290Dial-in (International): +1 240-690-8800Passcode:ALBQ4The company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com.About Albemarle
Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allow us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, Securities and Exchange Commission ("SEC") filings and other information regarding the company, its businesses and the markets it serves.Forward-Looking Statements
This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "ambition," "anticipate," "believe," "estimate," "expect," "goal," "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will". Forward-looking statements may include statements regarding: our 2026 company and segment outlooks, including expected market pricing of lithium carbonate equivalent and spodumene and other underlying assumptions and outlook considerations; planned sale of a controlling stake in Ketjen and the amount of the proceeds for the controlling stake in Ketjen and our interest in the Eurecat JV; timing for completion of both transactions, including obtaining regulatory approvals and meeting other closing conditions; expectations regarding use of proceeds from the both transactions; expected capital expenditure amounts and the corresponding impact on cash flow; expected impact of tariffs and other trade restrictions; plans and expectations regarding other projects and activities, cost reductions and accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; changes in trade policies and tariffs; financial and operating performance of customers; timing and magnitude of customer orders; fluctuations in lithium and spodumene market prices; production volume shortfalls; increased competition; changes in product demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; risks related to the integration of artificial intelligence technologies into our operations; geopolitical conflicts and political unrest; our ability to retain key personnel and attract new skilled personnel; changes in inflation or interest rates; volatility in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; performance of Albemarle's partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws. Albemarle Corporation and Subsidiaries
Consolidated Statements of (Loss) Income
(In Thousands Except Per Share Amounts) (Unaudited)
Three Months Ended
Year Ended
December 31,
December 31,
2025
2024
2025
2024Net sales$ 1,428,031
$ 1,231,713
$ 5,142,733
$ 5,377,526Cost of goods sold1,230,097
1,093,500
4,474,014
5,314,987Gross profit197,934
138,213
668,719
62,539Selling, general and administrative expenses155,500
135,996
550,036
618,048Goodwill impairment charges—
—
181,070
—Long-lived asset impairment charges245,600
—
245,600
—Restructuring charges and asset write-offs2,039
(22,206)
7,699
1,134,316Research and development expenses12,181
20,021
51,398
86,720Operating (loss) profit(217,386)
4,402
(367,084)
(1,776,545)Interest and financing expenses(57,776)
(44,703)
(207,651)
(165,619)Other (expenses) income, net(9,828)
117,028
22,662
178,339(Loss) income before income taxes and equity in net income of unconsolidated investments(284,990)
76,727
(552,073)
(1,763,825)Income tax expense157,330
10,613
156,881
87,085(Loss) income before equity in net income of unconsolidated investments(442,320)
66,114
(708,954)
(1,850,910)Equity in net income of unconsolidated investments (net of tax)40,560
18,997
243,744
715,433Net (loss) income(401,760)
85,111
(465,210)
(1,135,477)Net income attributable to noncontrolling interests(12,419)
(9,818)
(45,418)
(43,972)Net (loss) income attributable to Albemarle Corporation(414,179)
75,293
(510,628)
(1,179,449)Mandatory convertible preferred stock dividends(41,687)
(41,688)
(166,750)
(136,647)Net (loss) income attributable to Albemarle Corporation common shareholders$ (455,866)
$ 33,605
$ (677,378)
$ (1,316,096)Basic (loss) earnings per share attributable to common shareholders$ (3.87)
$ 0.29
$ (5.76)
$ (11.20)Diluted (loss) earnings per share attributable to common shareholders$ (3.87)
$ 0.29
$ (5.76)
$ (11.20)
Weighted-average common shares outstanding – basic117,701
117,549
117,664
117,516Weighted-average common shares outstanding – diluted117,701
117,723
117,664
117,516 Albemarle Corporation and SubsidiariesCondensed Consolidated Balance Sheets(In Thousands) (Unaudited)
December 31,
December 31,
2025
2024ASSETS
Current assets:
Cash and cash equivalents$ 1,618,001
$ 1,192,230 Trade accounts receivable593,502
742,201 Other accounts receivable105,110
238,384 Inventories1,179,271
1,502,531 Other current assets140,440
166,916 Current assets held for sale371,815
—Total current assets4,008,139
3,842,262Property, plant and equipment, at cost11,768,840
12,523,368Less accumulated depreciation and amortization3,156,429
3,191,898Net property, plant and equipment8,612,411
9,331,470Investments900,926
1,117,739Other assets647,185
504,711Goodwill1,499,657
1,582,714Other intangibles, net of amortization214,233
230,753Noncurrent assets held for sale491,660
—Total assets$ 16,374,211
$ 16,609,649LIABILITIES AND EQUITY
Current liabilities:
Accounts payable to third parties$ 779,160
$ 793,455 Accounts payable to related parties134,369
150,432 Accrued expenses521,831
467,997 Current portion of long-term debt74,077
398,023 Dividends payable61,387
61,282 Income taxes payable35,467
95,275 Current liabilities held for sale191,753
—Total current liabilities1,798,044
1,966,464Long-term debt3,119,464
3,118,142Postretirement benefits44,744
31,930Pension benefits117,361
116,192Other noncurrent liabilities1,084,892
819,204Deferred income taxes368,275
358,029Noncurrent liabilities held for sale59,970
—Commitments and contingencies
Equity:
Albemarle Corporation shareholders' equity:
Common stock1,178
1,176 Mandatory convertible preferred stock2,235,105
2,235,105 Additional paid-in-capital3,018,213
2,985,606 Accumulated other comprehensive loss(334,807)
(742,062) Retained earnings4,613,676
5,481,692Total Albemarle Corporation shareholders' equity9,533,365
9,961,517Noncontrolling interests248,096
238,171Total equity9,781,461
10,199,688Total liabilities and equity$ 16,374,211
$ 16,609,649 Albemarle Corporation and SubsidiariesSelected Consolidated Cash Flow Data(In Thousands) (Unaudited)
Year Ended
December 31,
2025
2024Cash and cash equivalents at beginning of year$ 1,192,230
$ 889,900Cash flows from operating activities:
Net loss(465,210)
(1,135,477)Adjustments to reconcile net loss to cash flows from operating activities:
Depreciation and amortization658,678
588,638Non-cash goodwill impairment charges181,070
—Non-cash long-lived asset impairment charges245,600
—Non-cash restructuring and asset write-offs—
1,013,444Stock-based compensation and other40,271
32,141Equity in net income of unconsolidated investments (net of tax)(243,744)
(715,433)Dividends received from unconsolidated investments and nonmarketable securities93,739
358,933Pension and postretirement expense (benefit)23,377
(5,274)Pension and postretirement contributions(20,441)
(19,379)Realized loss on investments in marketable securities—
33,746Unrealized (gain) loss on investments in marketable securities(14,088)
30,073Loss on early extinguishment of debt7,471
—Deferred income taxes81,169
(230,406)Changes in current assets and liabilities, net of effects of acquisitions and divestitures:
Decrease in accounts receivable47,315
555,218Decrease in inventories212,351
1,055,036Decrease in other current assets4,027
244,987Increase (decrease) in accounts payable to third parties144,208
(462,839)(Decrease) in accounts payable to related parties(16,063)
(399,398)(Decrease) in accrued expenses and income taxes payable(36,753)
(140,099)Noncurrent liability changes and other, net339,290
(116,035)Net cash provided by operating activities1,282,267
687,876Cash flows from investing activities:
Capital expenditures(589,801)
(1,680,529)Proceeds from sale of property and equipment32,812
29,102Proceeds from sale of investments290,908
—Proceeds (payments) from settlement of foreign currency forward contracts, net114,236
(15,595)Sales of marketable securities, net6,077
82,520Investments in equity investments and nonmarketable securities(239)
(270)Net cash used in investing activities(146,007)
(1,584,772)Cash flows from financing activities:
Proceeds from issuance of mandatory convertible preferred stock—
2,236,750Proceeds from borrowings of long-term debt and credit agreements56,728
112,439Repayments of long-term debt and credit agreements(505,736)
(112,439)Other repayments, net(5,657)
(631,834)Dividends paid to common shareholders(190,530)
(188,530)Dividends paid to mandatory convertible preferred shareholders(166,750)
(122,746)Dividends paid to noncontrolling interests(18,169)
(37,194)Proceeds from exercise of stock options3,240
374Withholding taxes paid on stock-based compensation award distributions(7,258)
(11,891)Other(55)
(3,194)Net cash (used in) provided by financing activities(834,187)
1,241,735Net effect of foreign exchange on cash and cash equivalents123,698
(42,509)Increase in cash and cash equivalents425,771
302,330Cash and cash equivalents at end of period$ 1,618,001
$ 1,192,230 Albemarle Corporation and SubsidiariesConsolidated Summary of Segment Results(In Thousands) (Unaudited)
Three Months Ended
Year Ended
December 31,
December 31,
2025
2024
2025
2024Net sales:
Energy Storage$ 759,059
$ 616,822
$ 2,710,035
$ 3,015,121Specialties348,901
332,942
1,366,435
1,325,983Ketjen320,071
281,949
1,066,263
1,036,422Total net sales$ 1,428,031
$ 1,231,713
$ 5,142,733
$ 5,377,526
Adjusted EBITDA:
Energy Storage$ 167,058
$ 133,678
$ 697,215
$ 757,540Specialties68,552
72,875
275,739
228,504Ketjen49,677
35,778
150,398
131,066 Total segment adjusted EBITDA285,287
242,331
1,123,352
1,117,110Corporate(16,543)
8,353
(25,359)
22,668Total adjusted EBITDA$ 268,744
$ 250,684
$ 1,097,993
$ 1,139,778
See accompanying non-GAAP reconciliations below.Additional Information regarding Non-GAAP MeasuresIt should be noted that adjusted net (loss) income attributable to Albemarle Corporation, adjusted net loss attributable to Albemarle Corporation common shareholders, adjusted diluted loss per share attributable to common shareholders, non-operating pension and other post-employment benefit ("OPEB") items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin and adjusted EBITDA margin, operating cash flow conversion, and free cash flow are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net (loss) income attributable to Albemarle Corporation ("earnings") or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company's operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company's chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also available on Albemarle's website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliations
(Unaudited)See below for a reconciliation of adjusted net (loss) income attributable to Albemarle Corporation, adjusted net loss attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net (loss) income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net loss attributable to Albemarle Corporation is defined as net loss attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net loss attributable to Albemarle Corporation common stockholders is defined as adjusted net loss attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net (loss) income attributable to Albemarle Corporation before interest and financing expenses, income tax expense, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring, other unusual and non-operating pension and OPEB items as listed below.
Three Months Ended
Year Ended
December 31,
December 31,
2025
2024
2025
2024In thousands, except percentages and pershare amounts$
% of
net
sales
$
% of
net
sales
$
% of
net
sales
$
% of
net
salesNet (loss) income attributable to AlbemarleCorporation$ (414,179)
$ 75,293
$ (510,628)
$ (1,179,449)
Add back:
Non-operating pension and OPEB items(net of tax)18,181
(8,014)
18,664
(9,045)
Non-recurring and other unusual items(net of tax)375,554
(153,490)
566,087
1,049,823
Adjusted net (loss) income attributable toAlbemarle Corporation$ (20,444)
$ (86,211)
$ 74,123
$ (138,671)
Mandatory convertible preferredstock dividends(41,687)
(41,688)
(166,750)
(136,647)
Adjusted net loss attributable toAlbemarle Corporation common shareholders$ (62,131)
$ (127,899)
$ (92,627)
$ (275,318)
Adjusted diluted loss per share attributable tocommon shareholders$ (0.53)
$ (1.09)
$ (0.79)
$ (2.34)
Adjusted weighted-average common sharesoutstanding – diluted117,701
117,549
117,664
117,516
Net (loss) income attributable toAlbemarle Corporation$ (414,179)
(29.0) %
$ 75,293
6.1 %
$ (510,628)
(9.9) %
$ (1,179,449)
(21.9) %Add back:
Interest and financing expenses57,776
4.0 %
44,703
3.6 %
207,651
4.0 %
165,619
3.1 %Income tax expense157,330
11.0 %
10,613
0.9 %
156,881
3.1 %
87,085
1.6 %Depreciation and amortization163,710
11.5 %
163,106
13.2 %
658,678
12.8 %
588,638
10.9 %EBITDA(35,363)
(2.5) %
293,715
23.8 %
512,582
10.0 %
(338,107)
(6.3) %Proportionate share of Windfield incometax expense16,050
1.1 %
6,201
0.5 %
94,549
1.8 %
299,193
5.6 %Non-operating pension and OPEB items16,732
1.2 %
(10,342)
(0.8) %
17,710
0.3 %
(11,335)
(0.2) %Non-recurring and other unusual items271,325
19.0 %
(38,890)
(3.2) %
473,152
9.2 %
1,190,027
22.1 %Adjusted EBITDA$ 268,744
18.8 %
$ 250,684
20.4 %
$ 1,097,993
21.4 %
$ 1,139,778
21.2 %
Net sales$ 1,428,031
$ 1,231,713
$ 5,142,733
$ 5,377,526
Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle's operating segments and are included in the Corporate category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company's businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other (expenses) income, net. Non-operating pension and OPEB items were as follows (in thousands):
Three Months Ended
Year Ended
December 31,
December 31,
2025
2024
2025
2024MTM actuarial loss (gain)$ 17,246
$ (9,831)
$ 17,246
$ (9,831)Interest cost8,717
8,696
35,427
34,225Expected return on assets(9,231)
(9,207)
(34,963)
(35,729)Total$ 16,732
$ (10,342)
$ 17,710
$ (11,335)In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle's adjusted net (loss) income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):
Three Months Ended
Year Ended
December 31,
December 31,
2025
2024
2025
2024Restructuring charges and asset write-offs(1)$ 0.02
$ (0.21)
$ 0.04
$ 9.77Goodwill impairment charges(2)0.04
—
1.54
—Long-lived asset impairment charges(3)2.09
—
2.09
—Acquisition and integration related costs(4)0.04
0.01
0.07
0.04(Gain) loss in fair value of public equity securities(5)(0.07)
0.03
(0.09)
0.53Loss on extinguishment of debt(6)0.06
—
0.06
—Other(7)0.28
(0.19)
0.35
(0.42)Tax related items(8)0.73
(0.95)
0.75
(1.00)Total non-recurring and other unusual items$ 3.19
$ (1.31)
$ 4.81
$ 8.92
(1)
The Company took several actions during 2024 as part of a broader effort that are focused on preserving its world-class resource advantages, optimizing its global conversion network, improving the Company's cost competitiveness and efficiency, reducing capital intensity and enhancing the Company's financial flexibility. Those actions included stopping construction of Kemerton Trains 3 and 4, as well as certain other capital projects, placing Kemerton Train 2 in care and maintenance and transitioning the Company's operating structure to a fully integrated functional model (excluding Ketjen). Additionally, as part of this restructuring plan, we placed the Chengdu, China conversion plant into care and maintenance during the first half of 2025. As a result, the Company recorded restructuring and asset write-off charges of $2.0 million and $7.7 million in Restructuring charges and asset write-offs for the three months and year ended December 31, 2025, respectively, and a loss of $0.1 million and $0.2 million in Other (expenses) income, net for the three months and year ended December 31, 2025, respectively. Due to the impact of the valuation allowances, this resulted in total after-tax gains of $2.2 million and $5.2 million, or $0.02 and $0.04 per share for the three months and year ended December 31, 2025, respectively. The Company recorded restructuring and asset write-off charges (gains) of $3.8 million in Cost of goods sold during the three months and year ended December 31, 2024, and ($22.2) million and net charges of $1.2 billion during the three months and year ended December 31, 2024, respectively in Restructuring charges and asset write-offs. In addition, losses of $4.6 million and $26.1 million were recorded in Other (expenses) income, net for the three months and year ended December 31, 2024, respectively, related to these actions. In total, this resulted in after-tax (gains) losses of ($24.9) million and $1.1 billion, or ($0.21) and $9.77 per share for the three months and year ended December 31, 2024, respectively. The tax impact includes a valuation allowance to reverse the tax benefits associated with the expenses recorded in Australia.
(2)
Non-cash goodwill impairment charge of $181.1 million ($181.1 million or $1.54 per share after income tax expense) recorded during the year ended December 31, 2025 related to our Refining Solutions business within our Ketjen reportable segment.
(3)
Non-cash long-lived asset impairment charge of $245.6 million ($245.6 million or $2.09 per share after income tax expense) recorded during the three months and year ended December 31, 2025 to reduce the carrying value of our Refining Solutions business to its fair value less costs to sell following classification as held for sale.
(4)
Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three months and year ended December 31, 2025 were $3.2 million and $8.3 million ($4.3 million and $8.3 million after income taxes due to the impact of valuation allowances, or $0.04 and $0.07 per share), respectively, and for the three months and year ended December 31, 2024 were $2.3 million and $6.2 million ($1.8 million and $4.9 million after income taxes, or $0.01 and $0.04 per share), respectively.
(5)
Gains of $8.0 million and $11.1 million ($8.7 million and $11.1 million after income taxes due to the impact of valuation allowances, or $0.07 and $0.09 per share) recorded in Other (expenses) income, net resulting from the net change in fair value of investments in public equity securities for the three months and year ended December 31, 2025, respectively. Losses of $4.8 million and $37.0 million recorded in Other (expenses) income, net resulting from the net change in fair value of investments in public equity securities for the three months and year ended December 31, 2024, respectively, and a loss of $33.7 million recorded in Other (expenses) income, net for the year ended December 31, 2024 resulting from the sale of investments in public equity securities ($3.7 million and $62.7 million after income taxes, or $0.03 and $0.53 per share).
(6)
Included in Interest and financing expenses for the three months and year ended December 31, 2025 is a loss on early extinguishment of debt of $7.5 million ($0.06 per share, with no adjustment from income taxes due to the impact of valuation allowances), representing the unamortized discounts from the amendment of other debt.
(7)
Other adjustments for the three months ended December 31, 2025 included amounts recorded in:
•Cost of goods sold - $4.8 million related to the write-off of assets damaged in a severe weather incident in Jordan.
•Selling, general and administrative expenses - $9.2 million related to the write-off of assets damaged in a severe weather incident in Jordan and $0.8 million related to the write-off of certain fixed assets, partially offset by a $0.7 million gain resulting from the adjustment of severance expenses not related to a restructuring plan.
•Other (expenses) income, net - $14.3 million loss related to the sale of our ownership interest in the Nippon Aluminum Alkyls joint venture.
After income taxes, these net losses totaled $33.1 million, or $0.28 per share.
Other adjustments for the year ended December 31, 2025 included amounts recorded in:
•Cost of goods sold - $4.8 million related to the write-off of assets damaged in a severe weather incident in Jordan.
•Selling, general and administrative expenses - $9.2 million related to the write-off of assets damaged in a severe weather incident in Jordan, $3.1 million of severance expenses not related to a restructuring plan, $2.2 million related to the write-off of certain fixed assets, $2.0 million of expenses related to certain historical legal matters and $1.4 million of expenses related to the redemption of preferred equity in a Grace subsidiary, partially offset by $13.3 million of gains from the sale of assets not part of our production operations.
•Other (expenses) income, net - $38.0 million loss resulting from the redemption of preferred equity in a Grace subsidiary, $14.3 million loss related to the sale of our ownership interest in the Nippon Aluminum Alkyls joint venture and $1.9 million of charges for asset retirement obligations at a site not part of our operations, partially offset by $19.8 million of income from PIK dividends of the preferred equity in a Grace subsidiary prior to redemption and a $2.4 million gain primarily resulting from the adjustment of indemnification related to previously disposed businesses.
After income taxes, these net losses totaled $41.5 million, or $0.35 per share.
Other adjustments for the three months ended December 31, 2024 included amounts recorded in:
•Other (expenses) income, net - $23.5 million of gains from the sale of assets at a site not part of our operations, $9.5 million of income from PIK dividends of preferred equity in a Grace subsidiary, a $1.4 million net gain primarily resulting from the adjustment of indemnification related to previously disposed businesses, partially offset by $2.1 million of a loss related to the fair value adjustment of a nonmarketable security investment.
After income taxes, these net gains totaled $22.7 million, or $0.19 per share.
Other adjustments for the year ended December 31, 2024 included amounts recorded in:
•Cost of goods sold - $1.4 million of expenses related to non-routine labor and compensation related costs that are outside normal compensation arrangements.
•Selling, general and administrative - $5.3 million of expenses related to certain historical legal and environmental matters.
•Other (expenses) income, net - $40.9 million of gains from the sale of assets at sites not part of our operations, $36.3 million of income from PIK dividends of preferred equity in a Grace subsidiary, a $1.8 million net gain primarily resulting from the adjustment of indemnification related to previously disposed businesses and a $0.6 million gain from an updated cost estimate of an environmental reserve at a site not part of our operations, partially offset by $2.9 million of charges for asset retirement obligations at a site not part of our operations and $2.1 million of a loss related to the fair value adjustment of a nonmarketable security investment.
After income taxes, these net gains totaled $49.0 million, or $0.42 per share.
(8)
Included in Income tax expense for the three months and year ended December 31, 2025 are discrete net tax expenses of $86.2 million, or $0.73 per share, and $88.1 million, or $0.75 per share, respectively, primarily related to a U.S. basis difference in Ketjen entities.
Included in Income tax expense for the three months and year ended December 31, 2024 are discrete net tax benefits of $111.4 million, or $0.95 per share, and $117.5 million, or $1.00 per share, respectively, primarily related to the impact of valuation allowances on a return to provision, partially offset by the increase in a foreign tax reserve.See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).
(Loss) incomebefore income taxesand equity in netincome ofunconsolidatedinvestments
Income tax expense(benefit)
Effective incometax rateThree months ended December 31, 2025:
As reported$ (284,990)
$ 157,330
(55.2) %Non-recurring, other unusual and non-operating pension and OPEB items295,527
(98,208)
As adjusted$ 10,537
$ 59,122
561.1 %
Three months ended December 31, 2024:
As reported$ 76,727
$ 10,613
13.8 %Non-recurring, other unusual and non-operating pension and OPEB items(49,232)
112,272
As adjusted$ 27,495
$ 122,885
446.9 %
Year ended December 31, 2025:
As reported$ (552,073)
$ 156,881
(28.4) %Non-recurring, other unusual and non-operating pension and OPEB items498,332
(86,419)
As adjusted$ (53,741)
$ 70,462
(131.1) %
Year ended December 31, 2024:
As reported$ (1,763,825)
$ 87,085
(4.9) %Non-recurring, other unusual and non-operating pension and OPEB items1,178,692
137,914
As adjusted$ (585,133)
$ 224,999
(38.5) %See below for the calculation of operating cash flow conversion and a reconciliation of free cash flow, a non-GAAP measure, to net cash provided by operating activities, the most directly comparable financial measure calculated and reporting in accordance with GAAP. The Company defines as Net cash provided by operating activities from the statement of cash flows divided by adjusted EBITDA, which is a non-GAAP measure. A reconciliation of adjusted EBITDA, the non-GAAP financial measure, from net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reporting in accordance with GAAP, is provided in the above tables (in thousands, except percentages).
Year Ended
December 31, 2025Free cash flow:
Net cash provided by operating activities$ 1,282,267Less: Capital expenditures(589,801)Free cash flow$ 692,466
Operating cash flow conversion:
Net cash provided by operating activities$ 1,282,267
Adjusted EBITDA$ 1,097,993
Operating cash flow conversion117 % Albemarle Investor Relations Contact: +1 (980) 308-6194, invest@albemarle.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-reports-fourth-quarter-and-full-year-2025-results-302685449.htmlSOURCE Albemarle Corporation
Original: Albemarle Reports Fourth Quarter and Full Year 2025 Results